EUROBIO-SCIENTIFIC (ALERS.PA) Stock Cash Flow
EPA:ALERS - Euronext Paris - Matif - FR0013240934 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 6.64M | 4.83M | 24.94M | 60.54M | 73.48M | |||
| Depreciation Amortization | 14.93M | 14.25M | 9.22M | 6.94M | 7.27M | |||
| Income Taxes - Deferred | -1.25M | -1.79M | 1.32M | 1.64M | 1.53M | |||
| Change In Working Capital | 2.30M | 8.35M | 8.84M | -3.67M | -28.27M | |||
| Other non cash items | 451.00K | 1.12M | -1.25M | 455.00K | 920.00K | |||
| OPERATING CASH FLOW | 23.07M | 26.77M | 43.07M | 65.92M | 54.93M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.12M | -4.05M | -2.83M | -1.85M | -2.30M | |||
| Other Investing Activity | 18.51M | 3.74M | -138.92M | -3.62M | -1.69M | |||
| INVESTING CASH FLOW | 15.39M | -318.00K | -141.76M | -5.47M | -3.98M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -17.53M | -18.20M | 95.75M | -15.96M | 9.70M | |||
| Stock Issued/Repurchased | -2.90M | -2.79M | -12.24M | -6.91M | -247.00K | |||
| Other Financing Activity | -2.30M | -2.51M | -1.21M | -882.00K | -2.40M | |||
| FINANCING CASH FLOW | -22.73M | -23.50M | 82.31M | -23.75M | 7.05M | |||
| Exchange Rate Effect | 104.00K | 147.00K | -77.00K | 138.00K | -60.00K | |||
| CHANGE IN CASH | 15.84M | 3.09M | -16.45M | 36.83M | 57.94M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 23.07M | 26.77M | 43.07M | 65.92M | 54.93M | |||
| Capital Expenditure | -3.12M | -4.05M | -2.83M | -1.85M | -2.30M | |||
| FREE CASH FLOW | 19.96M | 22.71M | 40.24M | 64.07M | 52.63M | |||
All data in EUR